Bausch + Lomb (BLCO) posted mixed fourth quarter results. Although adjusted earnings per share (EPS) came in shy of analyst consensus, the company also posted its highest-ever revenue and EBITDA ...
Staar Surgical (Nasdaq:STAA) announced that it received FDA approval for an expanded age indication for its Evo lenses.